[Oral therapy of cardiac arrhythmia using Neo-Gilurytmal (N-n-propyl-ajmalinium-hydrogentartrate)].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000404:Ajmaline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013644:Tartrates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013644:Tartrates; D000404:Ajmaline; D010672:Phenytoin; D008012:Lidocaine; D011342:Procainamide
Neo-Gilurytmal (N-n-propyl-ajmalinium-hydrogentartrat) in der oralen Therapie von Herzrhythmusstörungen.